Background Patients with hematological malignancies (HM) are at high risk of mortality from
SARS-CoV-2 disease 2019 (COVID-19). A better understanding of risk factors for adverse …

HIV infection is associated with a high incidence of AIDS-related lymphomas (ARLs). Since
the use of highly active antiretroviral therapy (HAART), the incidence of AIDS-defining …

Richter syndrome (RS) represents the development of diffuse large B-cell lymphoma in the
context of chronic lymphocytic leukemia. The scarcity of biologic information about RS has …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel virus that spread
worldwide from 2019 causing the Coronavirus disease 19 (COVID-19) pandemic. SARS-…

Purpose: Few biological prognosticators are useful for prediction of Richter syndrome (RS),
representing the transformation of chronic lymphocytic leukemia (CLL) to aggressive …

It is suspected that primary central nervous system lymphoma ( PCNSL ) rates are increasing
among immunocompetent people. We estimated PCNSL trends in incidence and survival …

Hepatitis C virus (HCV) has been associated with the development of B-cell non-Hodgkin
lymphomas. We recently reported the regression of splenic lymphoma with villous lymphocytes …

Regression of hepatitis C virus (HCV)–associated lymphoma with interferon (IFN)-based
antiviral treatment supports an etiological link between lymphoma and HCV infection. In addition…

Patients with hematological malignancy and COVID-19 display a high mortality rate. In such
patients, immunosuppression due to underlying disease and previous specific treatments …

Epstein-Barr virus (EBV) infection in humans is a major trigger of malignant and nonmalignant
B cell proliferations. CD27 is a co-stimulatory molecule of T cells, and inherited CD27 …